drugset / Trial / NCT00565461

LT Vaccine Patch Self-Administration Study

NCT00565461 ↗

Phase 2 Completed 160 enrolled Intercell USA, Inc.
RandomizedParallel-groupOpen-labelPrevention

Summary

To evaluate the immune responses achieved following self-administered heat-labile enterotoxin of E. coli (LT) vaccination by transcutaneous immunization compared to the immune responses achieved by clinician-administered vaccination.

Timeline

Start
2007-11
Primary completion
2008-07
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject heat-labile enterotoxin of E. coli (LT) Vaccine 37.5 ug Topical

Indications

No indication recorded.